A biocompatible chemically modified mrna drives sustained vegf-a protein production, human endothelial angiogenesis and epicardial progenitor expansion, and reduces infarct size and partially reverses global cardiac dysfunction when intracardially injected one week post-myocardial infarction in the pig

This article has no abstract
Epistemonikos ID: ea6d0ca49ca7b06b1d9f49711cc211c20c3a232d
First added on: Feb 08, 2025